We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Eversheds Sutherland’s equity capital markets practice in Stockholm remains at the forefront of the small and mid-cap growth segments in Sweden, with the team regularly handling IPOs and rights issuances on Nasdaq First North Growth Market and Spotlight Stock Market, as well as ABBs, takeovers, and reverse-takeovers. Practice head Johan Engström advises Swedish and international growth companies in the tech, gaming, financial services, life sciences, and crypto spaces. Mark Falkner, promoted to partner in January 2024, handles IPOs, rights issuances, ABBs, and incentive programs as well as corporate governance and compliance matters. Senior associate Kevin Holmkvist is also a key contact.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘A team with experience and a proactive approach to delivering a high-quality service. They have also provided some creative problem solving for our company.’
- 'Johan Engström has been an outstanding professional, partner, and colleague over the last 4-5 years of working with him. The energy and culture he brings has created an environment that produces a powerhouse of talent.'
Key clients
- Alpcot Holding AB (publ)
- Pharmacolog i Uppsala AB
Work highlights
- Advised Peptonic Medical AB, listed on Spotlight Stock Market, on the merger with Pharmiva AB (publ), listed on Nasdaq First North Growth Market.
- Advised PMD Device Solutions on its listing on Nasdaq First North Growth Market through a reverse takeover.